Cite
Dry powder aerosolization of a recombinant surfactant protein-C-based surfactant for inhalative treatment of the acutely inflamed lung*.
MLA
Ruppert, Clemens, et al. “Dry Powder Aerosolization of a Recombinant Surfactant Protein-C-Based Surfactant for Inhalative Treatment of the Acutely Inflamed Lung*.” Critical Care Medicine, vol. 38, no. 7, July 2010, pp. 1584–91. EBSCOhost, https://doi.org/10.1097/CCM.0b013e3181dfcb3b.
APA
Ruppert, C., Kuchenbuch, T., Boensch, M., Schmidt, S., Mathes, U., Hillebrand, V., Henneke, I., Markart, P., Reiss, I., Schermuly, R. T., Seeger, W., & Günther, A. (2010). Dry powder aerosolization of a recombinant surfactant protein-C-based surfactant for inhalative treatment of the acutely inflamed lung*. Critical Care Medicine, 38(7), 1584–1591. https://doi.org/10.1097/CCM.0b013e3181dfcb3b
Chicago
Ruppert, Clemens, Tim Kuchenbuch, Marc Boensch, Sebastian Schmidt, Uwe Mathes, Vera Hillebrand, Ingrid Henneke, et al. 2010. “Dry Powder Aerosolization of a Recombinant Surfactant Protein-C-Based Surfactant for Inhalative Treatment of the Acutely Inflamed Lung*.” Critical Care Medicine 38 (7): 1584–91. doi:10.1097/CCM.0b013e3181dfcb3b.